marlotamig
marlotamig: 4 clinical trials tracked.
marlotamig evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about marlotamig, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 1 study sponsors
Clinical Trial Registry Records (4)
Combining Capecitabine/Oxaliplatin Chemotherapy With Cemiplimab Alone or in Combination With Fianlimab or REGN7075 for the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Primary endpoint: Pathologic complete response (pCR) rate
A Phase 2 Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Treatment-Experienced Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Primary endpoint: Objective response as assessed by the investigator per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1
A Randomized Phase 2 Platform Study to Evaluate Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for the Perioperative Treatment of Patients With Resectable Non-Small Cell Lung Cancer
Primary endpoint: Major pathologic response (MPR) rate as determined by central blinded independent pathology review (BIPR)
A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Primary endpoint: The incidence of Dose-Limiting Toxicities (DLTs) during the DLT period